The High-Cost Plan Tax, or “Cadillac Tax” was established in Section 49801 of the Patient Protection and Affordable Care Act (PPACA)1. Originally slated to be implemented in 2018, the tax has been twice delayed by Congressional action, most recently in January of 2018. Now scheduled to take effect in 2022, the excise tax will be levied on certain generous health plans.
On Monday, August 5th, 2019, Dr. A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design (V-BID), gave a lecture to the University of Michigan IHPI National Clinician Scholars Program in Ann Arbor, MI.
Media Coverage on IRS HSA Guidance Treasury Expands Health Savings Account Benefits for Individuals Suffering from Chronic Conditions U.S. Department of the Treasury Today, the U.S. Department of the Treasury expanded preventive care benefits that may be provided by high deductible heath plans (HDHPs) for a range of chronic conditions. Full Article Thune, Carper Applaud Release of Updated Treasury Guidance to Ensure Access to Critical Services and Drugs for Chronic Diseases U.S. Senators Thune and Carper Joint Press Release U.S. Sens. John Thune (R-S.D.) and Tom Carper (D-Del.) today applauded the U.S. Department of Treasury for expanding its preventive services safe harbor for health savings account-eligible high-deductible health plans (HDHPs) to cover certain chronic disease services and drugs on a pre-deductible basis. Full Article Trump Administration Moves to Shift Patients' Chronic Illness Costs to Insurers Wall Street Journal, Stephanie Armour Millions of Americans in high-deductible health plans [...]
July 17, 2019 — In response to a June Executive Order, the U.S. Department of the Treasury released Notice 2019-45, a guidance allowing HSA-HDHP plans the flexibility to cover specified medications and services used to treat chronic diseases prior to meeting the plan deductible.
Senators John Thune (R-SD) and Tom Carper (D-DE), introduced the Chronic Disease Management Act of 2019 in the Senate (S. 1948), followed by the introduction of the companion bill in the House of Representatives (H.R. 3709) by Representatives Earl Blumenauer (D-OR) and Tom Reed (R-NY).
This update features policy developments, media reports, and events supporting continued momentum for multiple V-BID Center initiatives from mid-February to early July 2019.
On Tuesday, June 25, 2019, Dr. A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the Public Sector HealthCare Rountable 2nd Annual Congressional Forum in Washington, DC.
S. 3200 – Chronic Disease Management Act of 2020 A bill to amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible. Full Text Summary Press Release S. 1948 – Chronic Disease Management Act of 2019 A bill to amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible. Full Text Summary Press Release S. 2410 and H.R. 4978 – Chronic Disease Management Act of 2018 A bill to amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible. Full Text Summary Press Release H.R. 5652 – Access to Better Care Act of [...]
On June 24, 2019, President Trump signed an executive order, and Senators John Thune (R-S.D.) and Ben Carper (D-DE) introduced bipartisan legislation that allow health savings account eligible high-deductible health plans (HSA-HDHPs) the flexibility to cover essential medications and services used to treat chronic diseases prior to meeting the plan deductible.
On Tuesday, May 7, 2019, Dr. A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the HealthCare 21 Business Coalition’s annual forum in Knoxville, TN.
This update features policy developments, media reports, and events supporting continued momentum for multiple V-BID Center initiatives from the end of 2018 through mid-February 2019.
On March 13, 2019, 170 leaders from across the country and the health care spectrum came together to discuss strategies for tackling some of the industry’s most relevant challenges at our 13th annual Summit.
Tuesday, March 12, 2019Jack Roth Stadium Club at "The Big House"5:00-6:00 pm | Stadium Tours Available5:30-7:00 pm | Welcome Reception7:00-8:30 pm | Dinner Wednesday, March 13, 2019Jack Roth Stadium Club at "The Big House"7:30-8:15 am | Continental Breakfast8:15-8:30 am | Welcome & Opening Remarks8:30-10:00 am | Session 1: Expanded Role of V-BID in Medicare Advantage and Commercial PlansSpeakers:Mark Atalla, Center for Medicare and Medicaid Innovation Melanie Egorin, U.S. House Ways and Means Committee Stephen Parente, University of MinnesotaModerator: Cliff Goodman, Lewin Group 10:00-10:15 am | Break10:15-11:45 am | Session 2: Removing Low-Value Services to Create 'Headroom' for High-Value CareSpeakers:Daniel Carey, Commonwealth of Virginia Gwen Darien, National Patient Advocate Foundation John Keats, Cigna Moderator: Cliff Goodman, Lewin Group 11:45 am-1:00 pm | Networking Lunch/Break12:00 - 12:45 pm | Stadium Tours Available1:00 pm-2:30 pm | Session 3: Innovative Approaches to Finance High-Cost, High-Value ServicesSpeakers:Daniel Klein, Patient Access Network Ted Okon, Community Oncology Alliance Moderator: Cliff Goodman, Lewin Group 2:30-2:45 pm | Break2:45-4:15 pm | Session 4: V-BID X: A Novel Plan Design to Lower Premiums [...]
[pdf-embedder url="http://vbidcenter.org/wp-content/uploads/2019/03/final-timeline-4.pdf" title="final timeline"]
February 25, 2019 – The Morning Consult has published an opinion-editorial co-authored by V-BID Center Director, Dr. A Mark Fendrick, and President & CEO of the PAN Foundation, Dan Klein.
